Company / Operating Cash Flow per Share
IRONWOOD PHARMACEUTICALS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.79
FY2025
5-year range
$0.79 / $1.75
FY2021-FY2025
Trend
-54.7%
vs FY2024
Sector context
#61 of 212
Health Care
What the data says
At $0.79, IRONWOOD PHARMACEUTICALS INC's operating cash flow per share ranks #61 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.71 in FY2017 to $1.75 in FY2024.
Based on SEC 10-K filings.
0.79 in FY2025 with a 3-year CAGR of -8.7%.
Declined from $1.19 to $0.79 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-85.0% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 54.7% year-over-year.
- Ranks #61 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.79 | -54.7% |
| FY2024 | $1.75 | +47.0% |
| FY2023 | $1.19 | +14.3% |
| FY2022 | $1.04 | -36.1% |
| FY2021 | $1.63 | +462.4% |
| FY2020 | -$0.45 | -747.8% |
| FY2019 | $0.07 | +138.8% |
| FY2018 | -$0.18 | +74.8% |
| FY2017 | -$0.71 | -273.9% |
| FY2016 | -$0.19 | +79.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026